DEN0005653MA - - Google Patents
Info
- Publication number
- DEN0005653MA DEN0005653MA DEN0005653MA DE N0005653M A DEN0005653M A DE N0005653MA DE N0005653M A DEN0005653M A DE N0005653MA
- Authority
- DE
- Germany
- Prior art keywords
- esters
- ester
- alcohols
- benzilic acid
- acid
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- UKXSKSHDVLQNKG-UHFFFAOYSA-N Benzilic acid Chemical class C=1C=CC=CC=1C(O)(C(=O)O)C1=CC=CC=C1 UKXSKSHDVLQNKG-UHFFFAOYSA-N 0.000 claims description 19
- -1 aliphatic alcohols Chemical class 0.000 claims description 15
- 229940087675 BENZILIC ACID Drugs 0.000 claims description 14
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 13
- 125000004432 carbon atoms Chemical group C* 0.000 claims description 6
- 150000001298 alcohols Chemical class 0.000 claims description 5
- 238000004519 manufacturing process Methods 0.000 claims description 4
- 229910052757 nitrogen Inorganic materials 0.000 claims description 4
- BRRVXFOKWJKTGG-UHFFFAOYSA-N 3,3,5-trimethylcyclohexanol Chemical compound CC1CC(O)CC(C)(C)C1 BRRVXFOKWJKTGG-UHFFFAOYSA-N 0.000 claims description 3
- 238000000034 method Methods 0.000 claims description 3
- RZKSECIXORKHQS-UHFFFAOYSA-N 3-Heptanol Chemical compound CCCCC(O)CC RZKSECIXORKHQS-UHFFFAOYSA-N 0.000 claims description 2
- 125000004433 nitrogen atoms Chemical group N* 0.000 claims description 2
- BBNYLDSWVXSNOQ-UHFFFAOYSA-N oxolane-2-carbaldehyde Chemical compound O=CC1CCCO1 BBNYLDSWVXSNOQ-UHFFFAOYSA-N 0.000 claims description 2
- HXQPUEQDBSPXTE-UHFFFAOYSA-N 2,6-dimethylheptan-4-ol Chemical compound CC(C)CC(O)CC(C)C HXQPUEQDBSPXTE-UHFFFAOYSA-N 0.000 claims 1
- BODRLKRKPXBDBN-UHFFFAOYSA-N 3,5,5-trimethylhexan-1-ol Chemical compound OCCC(C)CC(C)(C)C BODRLKRKPXBDBN-UHFFFAOYSA-N 0.000 claims 1
- VJYIBSANFPUGNL-UHFFFAOYSA-N C1(CCCCC1)O.C1(CCCC1)=O Chemical compound C1(CCCCC1)O.C1(CCCC1)=O VJYIBSANFPUGNL-UHFFFAOYSA-N 0.000 claims 1
- 150000002148 esters Chemical class 0.000 description 25
- 235000019441 ethanol Nutrition 0.000 description 16
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 8
- 230000002048 spasmolytic Effects 0.000 description 7
- 230000001225 therapeutic Effects 0.000 description 7
- IJGRMHOSHXDMSA-UHFFFAOYSA-N nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 6
- WSLDOOZREJYCGB-UHFFFAOYSA-N 1,2-dichloroethane Chemical compound ClCCCl WSLDOOZREJYCGB-UHFFFAOYSA-N 0.000 description 5
- WDIHJSXYQDMJHN-UHFFFAOYSA-L Barium chloride Chemical compound [Cl-].[Cl-].[Ba+2] WDIHJSXYQDMJHN-UHFFFAOYSA-L 0.000 description 4
- IWYDHOAUDWTVEP-UHFFFAOYSA-N Mandelic acid Chemical class OC(=O)C(O)C1=CC=CC=C1 IWYDHOAUDWTVEP-UHFFFAOYSA-N 0.000 description 4
- 230000002921 anti-spasmodic Effects 0.000 description 4
- 229940116229 Borneol Drugs 0.000 description 3
- 229930006709 borneol Natural products 0.000 description 3
- 230000000875 corresponding Effects 0.000 description 3
- 238000002360 preparation method Methods 0.000 description 3
- DTGKSKDOIYIVQL-WEDXCCLWSA-N (+)-borneol Chemical compound C1C[C@@]2(C)[C@@H](O)C[C@@H]1C2(C)C DTGKSKDOIYIVQL-WEDXCCLWSA-N 0.000 description 2
- NOOLISFMXDJSKH-KXUCPTDWSA-N (-)-(1R,3R,4S)-menthol Chemical compound CC(C)[C@@H]1CC[C@@H](C)C[C@H]1O NOOLISFMXDJSKH-KXUCPTDWSA-N 0.000 description 2
- 229960004873 LEVOMENTHOL Drugs 0.000 description 2
- 229940041616 Menthol Drugs 0.000 description 2
- ZQPPMHVWECSIRJ-KTKRTIGZSA-N Oleic acid Chemical compound CCCCCCCC\C=C/CCCCCCCC(O)=O ZQPPMHVWECSIRJ-KTKRTIGZSA-N 0.000 description 2
- XQYZDYMELSJDRZ-UHFFFAOYSA-N Papaverine Chemical compound C1=C(OC)C(OC)=CC=C1CC1=NC=CC2=CC(OC)=C(OC)C=C12 XQYZDYMELSJDRZ-UHFFFAOYSA-N 0.000 description 2
- 125000001931 aliphatic group Chemical group 0.000 description 2
- 238000009835 boiling Methods 0.000 description 2
- 239000000969 carrier Substances 0.000 description 2
- 239000000812 cholinergic antagonist Substances 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 238000005886 esterification reaction Methods 0.000 description 2
- NTYJJOPFIAHURM-UHFFFAOYSA-N histamine Chemical compound NCCC1=CN=CN1 NTYJJOPFIAHURM-UHFFFAOYSA-N 0.000 description 2
- 239000000203 mixture Substances 0.000 description 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 2
- CRVSVXOGJXPOSY-UHFFFAOYSA-N 2,2,6,6-tetramethylcyclohexan-1-ol Chemical compound CC1(C)CCCC(C)(C)C1O CRVSVXOGJXPOSY-UHFFFAOYSA-N 0.000 description 1
- LFEHSRSSAGQWNI-UHFFFAOYSA-N 2,6,8-trimethylnonan-4-ol Chemical compound CC(C)CC(C)CC(O)CC(C)C LFEHSRSSAGQWNI-UHFFFAOYSA-N 0.000 description 1
- RCYIBFNZRWQGNB-UHFFFAOYSA-N 2,6-dimethylheptan-1-ol Chemical compound CC(C)CCCC(C)CO RCYIBFNZRWQGNB-UHFFFAOYSA-N 0.000 description 1
- CETWDUZRCINIHU-UHFFFAOYSA-N 2-Heptanol Chemical compound CCCCCC(C)O CETWDUZRCINIHU-UHFFFAOYSA-N 0.000 description 1
- KQYRYPXQPKPVSP-UHFFFAOYSA-N 2-butylhexanoic acid Chemical compound CCCCC(C(O)=O)CCCC KQYRYPXQPKPVSP-UHFFFAOYSA-N 0.000 description 1
- 229930008281 A03AD01 - Papaverine Natural products 0.000 description 1
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Natural products CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 1
- 229960004373 Acetylcholine Drugs 0.000 description 1
- SESFRYSPDFLNCH-UHFFFAOYSA-N Benzyl benzoate Chemical compound C=1C=CC=CC=1C(=O)OCC1=CC=CC=C1 SESFRYSPDFLNCH-UHFFFAOYSA-N 0.000 description 1
- HPXRVTGHNJAIIH-UHFFFAOYSA-N Cyclohexanol Chemical compound OC1CCCCC1 HPXRVTGHNJAIIH-UHFFFAOYSA-N 0.000 description 1
- XCIXKGXIYUWCLL-UHFFFAOYSA-N Cyclopentanol Chemical compound OC1CCCC1 XCIXKGXIYUWCLL-UHFFFAOYSA-N 0.000 description 1
- 210000000936 Intestines Anatomy 0.000 description 1
- 229960005015 Local anesthetics Drugs 0.000 description 1
- 229940083877 Local anesthetics for treatment of hemorrhoids and anal fissures for topical use Drugs 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- UIIMBOGNXHQVGW-UHFFFAOYSA-M NaHCO3 Chemical class [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 description 1
- 239000005642 Oleic acid Substances 0.000 description 1
- 229960003207 Papaverine Hydrochloride Drugs 0.000 description 1
- 235000011054 acetic acid Nutrition 0.000 description 1
- 150000001243 acetic acids Chemical class 0.000 description 1
- OIPILFWXSMYKGL-UHFFFAOYSA-N acetylcholine Chemical compound CC(=O)OCC[N+](C)(C)C OIPILFWXSMYKGL-UHFFFAOYSA-N 0.000 description 1
- 239000000443 aerosol Substances 0.000 description 1
- 230000001476 alcoholic Effects 0.000 description 1
- 150000001414 amino alcohols Chemical class 0.000 description 1
- OKTJSMMVPCPJKN-UHFFFAOYSA-N carbon Chemical group [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 1
- 229910052799 carbon Inorganic materials 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 239000007795 chemical reaction product Substances 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 125000004494 ethyl ester group Chemical group 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 150000004820 halides Chemical class 0.000 description 1
- 125000000623 heterocyclic group Chemical group 0.000 description 1
- 229960001340 histamine Drugs 0.000 description 1
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 1
- 239000000543 intermediate Substances 0.000 description 1
- 239000003589 local anesthetic agent Substances 0.000 description 1
- 229940064003 local anesthetic throat preparations Drugs 0.000 description 1
- 229960002510 mandelic acid Drugs 0.000 description 1
- 238000002844 melting Methods 0.000 description 1
- 150000004702 methyl esters Chemical class 0.000 description 1
- 230000002911 mydriatic Effects 0.000 description 1
- PMZURENOXWZQFD-UHFFFAOYSA-L na2so4 Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O PMZURENOXWZQFD-UHFFFAOYSA-L 0.000 description 1
- 230000001264 neutralization Effects 0.000 description 1
- 239000002674 ointment Substances 0.000 description 1
- 229960001789 papaverine Drugs 0.000 description 1
- 230000035479 physiological effects, processes and functions Effects 0.000 description 1
- 150000003138 primary alcohols Chemical class 0.000 description 1
- ZTHYODDOHIVTJV-UHFFFAOYSA-N propyl 3,4,5-trihydroxybenzoate Chemical compound CCCOC(=O)C1=CC(O)=C(O)C(O)=C1 ZTHYODDOHIVTJV-UHFFFAOYSA-N 0.000 description 1
- 238000006748 scratching Methods 0.000 description 1
- 230000002393 scratching Effects 0.000 description 1
- 150000003333 secondary alcohols Chemical class 0.000 description 1
- 229910052938 sodium sulfate Inorganic materials 0.000 description 1
- 235000011152 sodium sulphate Nutrition 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 150000003509 tertiary alcohols Chemical class 0.000 description 1
- 230000002588 toxic Effects 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
Family
ID=
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE2230383C3 (de) | Phenoxyalkylcarbonsäurederivate und Verfahren zur Herstellung derselben | |
DE1801750C3 (de) | Prostaglandin-E-Carbinole und deren Tricarbonsäureester | |
DE2129124C3 (xx) | ||
DE1925065C3 (de) | 1 -Phenyläthyl-piperidinol-(4)-Verbindungen, Verfahren zu ihrer Herstellung und sie enthaltende Arzneimittel | |
DE962163C (de) | Verfahren zur Herstellung von spasmolytisch wirksamen Benzilsaeureestern | |
DEN0005653MA (xx) | ||
DE1620007C3 (de) | Decahydroisochinoline | |
CH628632A5 (de) | Verfahren zur herstellung von behensaeureestern von phenothiazinderivaten. | |
DE2038628C3 (de) | N,N'-Di(carboxyalkyI)-p-phenylendiamine, deren Salze und Diäthylester, Verfahren zu ihrer Herstellung und ihre Verwendung | |
DE2627985A1 (de) | 4-homoisotwistan-3-carbonsaeureester und verfahren zu ihrer herstellung | |
DE1593112B2 (de) | o-Hydroxybenzoyl hydrazon oder o Alkyloxy benzoyl hydrazone der Benztraubensaure und Verfahren zu deren Herstellung | |
DE2241241C3 (de) | Thiazolo eckige klammer auf 3.2-a eckige klammer zu -pyrimidinderivate, verfahren zu ihrer herstellung und sie enthaltende arzneimittel | |
DE2164988C3 (de) | 2,2-Diphenylcyclopropancarbonsäureesterderivate, Verfahren zu ihrer Herstellung und sie enthaltende Arzneimittel | |
DE763489C (de) | Verfahren zur Herstellung von ª-Aminoaethylestern substituierter Phenylessigsaeuren | |
CH660304A5 (de) | Antimykotische mittel mit hoher wirkstoff-freisetzung enthaltend bifonazol in form von loesung und spray. | |
CH644763A5 (de) | Szintigraphisches mittel und verfahren zu seiner herstellung. | |
AT92388B (de) | Verfahren zur Darstellung von Aralkylestern der Benzylamincarbonsäuren. | |
DE1493928C (de) | Basisch substituierte ß Tetrahydro furyl propionitnle und deren pharma kologisch nicht giftige Salze sowie Verfahren zu deren Herstellung | |
DE1620124C3 (de) | 8-Hydroxychinolinderivate | |
DE1795270C3 (de) | 1 -Hydroxy-2-pyridone | |
DE959277C (de) | Verfahren zur Herstellung von Benzilsaeure-[1-alkyl-piperidyl-(4)]-estern | |
AT211825B (de) | Verfahren zur Herstellung neuer basischer Benzilsäureesterderivate sowie deren Salze und quartären Ammoniumverbindungen | |
DE1470221A1 (de) | Piperidinomethylverbindungen und Verfahren zu ihrer Herstellung | |
DE1768406C (de) | Phenylacetylhydroxamsäuren. Ausscheidung aus: 1280254 | |
DE1445558C3 (de) | Piperid-2 -yl-1,3-dioxolane |